Jun 18, 2020
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 15, 2020
Arena Pharmaceuticals Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors
Jun 08, 2020
Arena Pharmaceuticals Announces R&D Leadership Transition
Jun 01, 2020
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
May 28, 2020
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
May 26, 2020
Arena Completes Full Enrollment of Etrasimod Phase 2 ADVISE Trial for Atopic Dermatitis, Provides Program Updates
May 22, 2020
Arena Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
May 20, 2020
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 13, 2020
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
May 07, 2020
Arena Announces Corporate Update and Reports First Quarter 2020 Financial Results
May 06, 2020
Arena Pharmaceuticals to Present at the Bank of America Securities Healthcare Conference on May 13
Apr 30, 2020
Arena Pharmaceuticals to Release First Quarter 2020 Financial Results and Provide Corporate Update on May 7
Apr 24, 2020
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 30, 2020
Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor
Feb 21, 2020
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 20, 2020
Arena Pharmaceuticals to Present at the Upcoming Investor Conferences
Feb 11, 2020
Arena Pharmaceuticals' Presence at the European Crohn's and Colitis Organisation (ECCO) Congress Further Highlights Commitment to the GI Community
Jan 16, 2020
FDA Grants Fast Track Designation to Arena Pharmaceuticals' APD418 for Development in Decompensated Heart Failure Patients
Jan 13, 2020
Arena Pharmaceuticals Appoints Joan Schmidt as Executive Vice President, General Counsel and Secretary
Jan 08, 2020
Arena Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 16